Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor?

Hurley MN, Smyth AR.

Curr Opin Pulm Med. 2018 Nov;24(6):586-591. doi: 10.1097/MCP.0000000000000518.

PMID:
30113336
2.

Staphylococcus aureus in cystic fibrosis: problem bug or an innocent bystander?

Hurley MN.

Breathe (Sheff). 2018 Jun;14(2):87-90. doi: 10.1183/20734735.014718.

3.

Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis.

Hurley MN, Fogarty A, McKeever TM, Goss CH, Rosenfeld M, Smyth AR.

Ann Am Thorac Soc. 2018 Jan;15(1):42-48. doi: 10.1513/AnnalsATS.201705-376OC.

4.

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.

Rowbotham NJ, Smith S, Leighton PA, Rayner OC, Gathercole K, Elliott ZC, Nash EF, Daniels T, Duff AJA, Collins S, Chandran S, Peaple U, Hurley MN, Brownlee K, Smyth AR.

Thorax. 2018 Apr;73(4):388-390. doi: 10.1136/thoraxjnl-2017-210473. Epub 2017 Aug 4.

5.

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.

Hurley MN; review co-authors, Prayle AP, Flume P.

Paediatr Respir Rev. 2015 Sep;16(4):246-8. doi: 10.1016/j.prrv.2015.07.002. Epub 2015 Jul 29. Review. No abstract available.

PMID:
26298057
6.

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.

Hurley MN, Prayle AP, Flume P.

Cochrane Database Syst Rev. 2015 Jul 30;(7):CD009730. doi: 10.1002/14651858.CD009730.pub2. Review.

PMID:
26226131
7.

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Lo DK, Hurley MN, Muhlebach MS, Smyth AR.

Cochrane Database Syst Rev. 2015 Feb 24;(2):CD009650. doi: 10.1002/14651858.CD009650.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Jul 21;7:CD009650.

PMID:
25927091
8.

Rate of improvement of CF life expectancy exceeds that of general population--observational death registration study.

Hurley MN, McKeever TM, Prayle AP, Fogarty AW, Smyth AR.

J Cyst Fibros. 2014 Jul;13(4):410-5. doi: 10.1016/j.jcf.2013.12.002. Epub 2014 Jan 10.

9.

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.

Hurley MN, Forrester DL, Smyth AR.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD008037. doi: 10.1002/14651858.CD008037.pub3. Review.

PMID:
23737089
10.

Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Lo DK, Hurley MN, Muhlebach MS, Smyth AR.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009650. doi: 10.1002/14651858.CD009650.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(2):CD009650.

PMID:
23450608
11.

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.

Hurley MN, Cámara M, Smyth AR.

Eur Respir J. 2012 Oct;40(4):1014-23. Epub 2012 Jun 27. Review.

12.

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.

Hurley MN, Prayle AP; Cochrane Cystic Fibrosis and Genetic Disorders Group.

Paediatr Respir Rev. 2012 Sep;13(3):160-1. doi: 10.1016/j.prrv.2012.04.005. Epub 2012 May 29. No abstract available.

PMID:
22726872
13.

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis.

Hurley MN, Ariff AH, Bertenshaw C, Bhatt J, Smyth AR.

J Cyst Fibros. 2012 Jul;11(4):288-92. doi: 10.1016/j.jcf.2012.02.006. Epub 2012 Mar 20.

14.

Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.

Prayle AP, Hurley MN, Smyth AR.

BMJ. 2012 Jan 3;344:d7373. doi: 10.1136/bmj.d7373.

PMID:
22214756
15.

Delayed publication of clinical trials in cystic fibrosis.

Hurley MN, Prayle AP, Smyth AR.

J Cyst Fibros. 2012 Jan;11(1):14-7. doi: 10.1016/j.jcf.2011.08.004. Epub 2011 Sep 1.

16.

Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis.

Prayle AP, Hurley MN, Smyth AR.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD008243. doi: 10.1002/14651858.CD008243.pub2. Review.

PMID:
21069703
17.

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.

Hurley MN, Forrester DL, Smyth AR.

Cochrane Database Syst Rev. 2010 Oct 6;(10):CD008037. doi: 10.1002/14651858.CD008037.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD008037.

PMID:
20927769

Supplemental Content

Loading ...
Support Center